LUPIN
Lupin LimitedNSEMarket Closed · NSE · INR
Open
₹2,114.7
High
₹2,116
Low
₹2,094.6
Prev Close
₹2,105
Market Cap
₹96.25 K Cr
Large Cap
P/E (TTM)
17.4
EPS
₹121.01
Div Yield
0.86%
P/B Ratio
4.27
ROE
24.7%
Key Metrics
Analyst Ratings(36 analysts)
Target Price
₹2,491
+18.3% upside
Current price: ₹2,105
What If I Had Invested?
Chart data not available for this range
AI Analysis
Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.
AI Technical Analysis
Buy/sell zones with live web research
Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.
Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.
About
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products,...
Technical Indicators
Quality scores
Valuation bands
Intrinsic value calculators
Peer Comparison
Dividend History
Recent: ₹30.00/shareRecent Filings (NSE)
Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.
Institutional Deals(NSE)
Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.
Governance Scorecard
AlphaView compositeFund Actions
News
News sourced from RSS feeds. Headlines link to original articles.
Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.